Picard Medical shares surge 89.60% after-hours following positive Emperor TAH data presentation at international conference.

Picard Medical surged 89.60% in after-hours trading following the unveiling of promising artificial heart data and the presentation of its Emperor Total Artificial Heart (TAH) at an international conference. The in vitro data highlighted the Emperor TAH’s elimination of external pneumatic drivers, autoregulation capabilities, and confirmation of surgical feasibility through its first in vivo implantation. These advancements, coupled with the device’s maintenance of SynCardia’s physiologic performance and support for future chronic studies, signaled strong clinical potential. The news directly aligned with the stock’s upward movement, as the results reinforced investor confidence in the company’s technological progress and long-term commercial viability.